Tannin Screening, Phenolic Compounds Analysis, and Antiproliferative Activity of Areca Nut Extract by Decreasing Ki-67 Protein in Oral Squamous Carcinoma Cell Lines

doi.org/10.26538/tjnpr/v4i9.12

Authors

  • Liza M. Sari Department of Oral Medicine, Faculty of Dentistry, University of Syiah Kuala, Banda Aceh, Indonesia
  • Dewi Wulandari Department of Clinical Pathology, Cipto Mangunkusumo Hospital, University of Indonesia, Jakarta, Indonesia
  • Arleni Bustami Integrated Cytogenetic and Cell Culture Laboratory, Cipto Mangunkusumo Hospital, University of Indonesia, Jakarta, Indonesia
  • Gus P. Subita Department of Oral Medicine, Faculty of Dentistry, University of Indonesia, Jakarta, Indonesia
  • Elza I. Auerkari Department of Oral Biology, Faculty of Dentistry, University of Indonesia, Jakarta, Indonesia

Keywords:

Cell-cycle, Oral squamous carcinoma, Quercetin, Catechin, Tannin

Abstract

The target of cancer therapy based on chemoradiotherapy or herbal medicine is to inhibit the cancer cell proliferation. Due to the current interest in the potential activity of areca nut extract, we investigated its ability to affect cell-cycle arrest and Ki-67 activity in Oral Squamous Carcinoma (OSC) cell lines. The tannin content was estimated by titrimetric analysis. The phenolic composition was analyzed using Liquid Chromatography-Mass Spectrometry (LCMS). Flow cytometry was performed for analyzing cell-cycle arrest and Ki-67 protein as an indicator of the proliferative activity in HSC-2 and HSC-3 cell lines. The areca nut extract showed 0.007% tannin, catechin, and quercetin. The cell-cycle arrest occurred in HSC-3 cells. The reduction of Ki-67 activities occurred in both cells after 24 hours. The areca nut extract has antiproliferative activity in OSC cell lines.

References

Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova, Tjulandin S, Shin DM, Cullen K, Ervin TJ. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007; 357:1705- 1715.

Hsu WH, Lee BH, Pan TM. Protection of Monascusfermented dioscorea against DMBA-induced oral injury in hamster by anti-inflammatory and antioxidative potentials. J Agric Food Chem. 2010; 58:6715-6720.

de Moraes M, Monteiro Maia CAD, de Almeida Freitas R, Galvao HC. Cell proliferation markers in oral squamouscell carcinoma. J Mol Biomark Diagn. 2012; S2:1-5.

Lee JH, Hong SM, Yun JY, Myoung H, Jin Kim M. Anticancer effects of cordycepin on oral squamous cell carcinoma proliferation and apoptosis in vitro. JCT 2011; 2:224-234.

Deng H, Sambrook PJ, Logan RM. The treatment of oralcancer: an overview for dental professionals. Aust Dent J 2011; 56:244-252.

Tolentino ES, Centurion BS, Ferreira LHC, de Souza AP, Damante JH, Rubira-Bulen IRF. Oral adverse effects of head and neck radiotherapy: literature review and suggestion of a clinical oral care guideline for irradiated patients. J Appl Oral Sci. 2011; 19(5):448-454.

Turner LL, Mupparapu M, Akintoye SO. Review of the complications associated with treatment of oropharyngeal cancer: A guide to the dental practitioner. Quintessence Int. 2013; 44(3):267-279.

Lutz NE, Falodun A, Kuhn J, Kragl U, Langer P, Nebe B. Pro-apoptotic and anti-adhesive effect of four African Plant extracts on the breast cancer cell line MCF-7. BMC Compl Altern Med. 2014; 334(14):1-13.

Sherr C. Cancer cell cycle. Sci. 1996; 274:1672-1677.

Vermeulen K, Bockstaele DRV, Berneman ZN. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 2003; 36:131-149.

Barnum KJ and O'Connell MJ. Cell cycle regulation by checkpoints. Meth Mol Biol. 2014; 1170:29-40.

Paulovich AG, Toczyski DP, Hartwell LH. When checkpoints fail. Cell 1997; 88:315-321.

Kajstura M, Halicka D, Pryjma J, Darzynkiewicz Z. Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete ‘‘Sub-G1’’ peaks on DNA content histograms. Cytometry Part A 2007; 71A:125-131.

Stewart ZA, Westfall MD, Pietenpol JA. Cell-cycle dysregulation and anticancer therapy. Trends Pharmacol Sci. 2003; 2(3):139-145.

Engel N, Oppermann C, Falodun A, Kragl U. Proliferative effects of five traditional Nigerian medicinal plant extracts on human breast and bone cancer cell lines. J Ethnopharmacol. 2011; 137:1003-1010.

Adamus A, Peer K, Ali I, Lise J, Falodun A, Frank M, Seitz G, Engel N. Berberis orthobotrys – A promising herbal antitumorigenic candidate for the treatment of pediatric alveolar rhabdomyosarcoma. J Ethnopharmacol. 2019; 229:262-271.

Olimid DA, Simionescu CE, Margaritescu CL, Florescu A. Immunoexpression of Ki67 and cyclin D1 in oral squamous carcinomas. Rom J Morphol Embryol. 2012; 53:795-798.

Li TJ, Browne RM, Matthews JB. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in unicystic ameloblastoma. Histopathol. 1994; 26:219-228.

Scholzen T and Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000; 182:311-322.

Sasaki K, Murakami T, Kawasaki M, Takahashi M. The cell cycle associated change of the Ki67 reactive nuclear antigen expression. J Cell Physiol. 1987; 133:579-584.

Humayun S and Prasad VR. Expression of p53 protein and ki-67 antigen in oral premalignant lesions and oral squamous cell carcinomas: An immunohistochemical study. Natl J Maxillofac Surg. 2011; 2(1):38-46.

Premalatha BR and Uma K. Analysis of KI-67 antigen in human Oral Squamous Cell Carcinoma – An immunohistochemical study. JIOH. 2010; 2:9-16.

Watanabe S, Watanabe R, Oton-Leite AF, de CG Alencar R, Oliviera JC, Leles CR, Batista AC, Mendonca EF. Analysis of cell proliferation and pattern of invaasion in oral squamous cell carcinoma. J Ora Sci. 2010; 52(3):417- 24.

Stoll C, Baretton G, Ahrens C, Lohrs U. Prognostic significance of apoptosis and associated factors in oral squamous cell carcinoma. Virchows Arch. 2000; 436(2):102-8.

World Health Organization. The International pharmacopoeia. 3 ed. Geneva; 2003.

AOAC official methods. Spectrophotometric method; 1965.

Falodun A, Engel-Lutz N, Oppermann C, Iftikhar A, Villinger A, Kragl U et al. Isolation of Trimethylammoniumyl - acetate monohydrate from Cola lepidota seeds: antiproliferative activity of extracts and fractions. J Herbs Spices Med Plants 2013; 19(4):329-339.

Sazwi NN, Nalina T, Rahim ZHA. Antioxidant and cytoprotective activities of Piper betle, Areca catechu, Uncaria gambir, and betel quid with and without calcium hydroxide. BMC Comp Alt Med. 2013; 13(351):1-12.

Kamiya Y and Ohshima T. The individual cell properties of oral squamous carcinoma and tumor suppressor gene mutation. Oral Sci Intl. 2005; 2(2):104-117.

Sari LM, Subita GP, Auerkari EI. Potential antioxidant and cytotoxic activity of areca nut (Areca catechu L.) extract in human oral squamous cell carcinoma and keratinocyte cells. Asian J Pharm Clin Res. 2017; 10(10):286-291.

Gurumurthy B. Diversity in Tannin and Fiber Content in Areca Nut (Areca catechu) Samples of Karnataka, India. Int J Curr Microbiol App Sci. 2018; 7(1):2899-906.

Gadkari PV and Balaramana M Catechins: Sources, extraction and encapsulation: A review Food Bioprod Process 2014; xxx:1-17.

Chen L and Zhang HY Cancer Preventive Mechanisms of the Green Tea Polyphenol (-)-Epigallocatechin-3-gallate. Mol. 2007; 12:946-957.

Park IJ, Lee YK, Hwang JT, Kwon DY, Ha J, Park OJ. Green tea catechin controls apoptosis in colon cancer cells by attenuation of H2O2-stimulated COX-2 expression via the AMPK signaling pathway at low-dose H2O2. Ann NY Acad Sci. 2009; 1171:538-544.

Mayr C, Wagner A, Neureiter D, Pichler M, Jakab M, Illig R, Berr F, Kiesslich T. The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells. BMC Compl Altern Med. 2015; 15(194):1-7.

Fassina G, Vene R, Morini M. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Clin Cancer Res. 2004; 10:4865- 4873.

Jung YD, Kim MS, Shin BA, Chay KO, Ahn BW, Liu W, Bucana CD, Gallick GE, Ellis LM. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer 2001; 84:844-850.

Deng HX, Song HY, Hou YF, Yuan GY, Zheng FJ. Effects of quercetin on the proliferation of breast cancer cells and expression of survivin in vitro. Exp Ther Med. 2013; 6:1155-1158.

Sari LM, Subita GP, Auerkari EI. Areca nut extract demonstrated apoptosis-inducing mechanism by increased caspase-3 activities on oral squamous cell carcinoma. F1000 Res. 2019:7:723.

Tang YQ, Jaganath IB, Sekaran SQ. Phyllanthus spp. induces selective growth inhibition of PC-3 and MeWo human cancer cells through modulation of cell cycle and induction of apoptosis. PLoS ONE 2010; 5(9):1-11.

Sakai E and Tsuchida N. Most human squamous cell carcinoma in the oral cavity contain mutated p53 tumor suppressor genes. Oncogen 1992; 7:927-933.

Myoung H, Hong S, Yun P, Lee JH, Kim MJ. Anticancer effect of genistein in oral squamous cell carcinoma with respect to angiogenesis and in vitro invasion. Cancer Sci. 2003; 94:215-220.

Garrett MD. Cell cycle control and cancer. Curr Sci. 2001; 81(5):515-522.

Downloads

Published

2020-09-01

How to Cite

Sari, L. M., Wulandari, D., Bustami, A., Subita, G. P., & Auerkari, E. I. (2020). Tannin Screening, Phenolic Compounds Analysis, and Antiproliferative Activity of Areca Nut Extract by Decreasing Ki-67 Protein in Oral Squamous Carcinoma Cell Lines: doi.org/10.26538/tjnpr/v4i9.12. Tropical Journal of Natural Product Research (TJNPR), 4(9), 563–570. Retrieved from https://tjnpr.org/index.php/home/article/view/1132

Issue

Vol. 4 No. 9 (2020): Tropical Journal of Natural Product Research

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.